Browse
You are looking at 31 - 40 of 77 items
The Bateson Centre, Firth Court, University of Sheffield, Western Bank, Sheffield, UK
Insigneo Institute for in silico Medicine, Sheffield, UK
Institute of Ophthalmology, Faculty of Brain Sciences, University College London, London, UK
Search for other papers by Elisabeth Kugler in
Google Scholar
PubMed
The Bateson Centre, Firth Court, University of Sheffield, Western Bank, Sheffield, UK
Search for other papers by Ryan Snodgrass in
Google Scholar
PubMed
The Bateson Centre, Firth Court, University of Sheffield, Western Bank, Sheffield, UK
Search for other papers by George Bowley in
Google Scholar
PubMed
The Bateson Centre, Firth Court, University of Sheffield, Western Bank, Sheffield, UK
Search for other papers by Karen Plant in
Google Scholar
PubMed
The Bateson Centre, Firth Court, University of Sheffield, Western Bank, Sheffield, UK
Search for other papers by Jovana Serbanovic-Canic in
Google Scholar
PubMed
The Bateson Centre, Firth Court, University of Sheffield, Western Bank, Sheffield, UK
Search for other papers by Noémie Hamilton in
Google Scholar
PubMed
The Bateson Centre, Firth Court, University of Sheffield, Western Bank, Sheffield, UK
Insigneo Institute for in silico Medicine, Sheffield, UK
Search for other papers by Paul C Evans in
Google Scholar
PubMed
The Bateson Centre, Firth Court, University of Sheffield, Western Bank, Sheffield, UK
Search for other papers by Timothy Chico in
Google Scholar
PubMed
Insigneo Institute for in silico Medicine, Sheffield, UK
Search for other papers by Paul Armitage in
Google Scholar
PubMed
The role of blood flow in vascular development is complex and context-dependent. In this study, we quantify the effect of the lack of blood flow on embryonic vascular development on two vascular beds, namely the cerebral and trunk vasculature in zebrafish. We perform this by analysing vascular topology, endothelial cell (EC) number, EC distribution, apoptosis, and inflammatory response in animals with normal blood flow or absent blood flow. We find that absent blood flow reduced vascular area and EC number significantly in both examined vascular beds, but the effect is more severe in the cerebral vasculature, and severity increases over time. Absent blood flow leads to an increase in non-EC-specific apoptosis without increasing tissue inflammation, as quantified by cerebral immune cell numbers and nitric oxide. Similarly, while stereotypic vascular patterning in the trunk is maintained, intra-cerebral vessels show altered patterning, which is likely to be due to vessels failing to initiate effective fusion and anastomosis rather than sprouting or path-seeking. In conclusion, blood flow is essential for cellular survival in both the trunk and cerebral vasculature, but particularly intra-cerebral vessels are affected by the lack of blood flow, suggesting that responses to blood flow differ between these two vascular beds.
Search for other papers by Sara Sileno in
Google Scholar
PubMed
Search for other papers by Sara Beji in
Google Scholar
PubMed
Search for other papers by Marco D’Agostino in
Google Scholar
PubMed
Search for other papers by Alessandra Carassiti in
Google Scholar
PubMed
Search for other papers by Guido Melillo in
Google Scholar
PubMed
Search for other papers by Alessandra Magenta in
Google Scholar
PubMed
Psoriasis is a chronic inflammatory disease involving the skin. Both genetic and environmental factors play a pathogenic role in psoriasis and contribute to the severity of the disease. Psoriasis, in fact, has been associated with different comorbidities such as diabetes, metabolic syndrome, gastrointestinal or kidney diseases, cardiovascular disease (CVD), and cerebrovascular diseases (CeVD). Indeed, life expectancy in severe psoriasis is reduced by up to 5 years due to CVD and CeVD. Moreover, patients with severe psoriasis have a higher prevalence of traditional cardiovascular (CV) risk factors, including dyslipidemia, diabetes, smoking, and hypertension. Further, systemic inflammation is associated with oxidative stress increase and induces endothelial damage and atherosclerosis progression. Different miRNA have been already described in psoriasis, both in the skin tissues and in the blood flow, to play a role in the progression of disease. In this review, we will summarize and discuss the most important miRNAs that play a role in psoriasis and are also linked to CVD.
Search for other papers by Gloria Garoffolo in
Google Scholar
PubMed
Search for other papers by Maurizio Pesce in
Google Scholar
PubMed
The role of mechanical forces is emerging as a new player in the pathophysiologic programming of the cardiovascular system. The ability of the cells to ‘sense’ mechanical forces does not relate only to perception of movement or flow, as intended traditionally, but also to the biophysical properties of the extracellular matrix, the geometry of the tissues, and the force distribution inside them. This is also supported by the finding that cells can actively translate mechanical cues into discrete gene expression and epigenetic programming. In the present review, we will contextualize these new concepts in the vascular pathologic programming.
Search for other papers by Ka Ka Ting in
Google Scholar
PubMed
Search for other papers by Paul Coleman in
Google Scholar
PubMed
Search for other papers by Yang Zhao in
Google Scholar
PubMed
Search for other papers by Mathew A Vadas in
Google Scholar
PubMed
Search for other papers by Jennifer R Gamble in
Google Scholar
PubMed
Cellular senescence is now recognized as one of the hallmarks of aging. Herein, we examine current findings on senescence of the vascular endothelium and its impacts on age-related vascular diseases. Endothelial senescence can result in systemic metabolic changes, implicating senescence in chronic diseases such as diabetes, obesity and atherosclerosis. Senolytics, drugs that eliminate senescent cells, afford new therapeutic strategies for control of these chronic diseases.
Search for other papers by Sashini Iddawela in
Google Scholar
PubMed
Search for other papers by Andrew Ravendren in
Google Scholar
PubMed
Search for other papers by Amer Harky in
Google Scholar
PubMed
The pathophysiology of thoracic aortic aneurysm and dissection is poorly understood, despite high mortality. An evidence review was conducted to examine the biomechanical, chemical and genetic factors involved in thoracic aortic pathology. The composition of connective tissue and smooth muscle cells can mediate important mechanical properties that allow the thoracic aorta to withstand and transmit pressures. Genetic syndromes can affect connective tissue and signalling proteins that interrupt smooth muscle function, leading to tissue failure. There are complex interplaying factors that maintain thoracic aortic function in health and are disrupted in disease, signifying an area for extensive research.
Search for other papers by Roberta Giordo in
Google Scholar
PubMed
Search for other papers by Panagiotis Paliogiannis in
Google Scholar
PubMed
Search for other papers by Arduino Aleksander Mangoni in
Google Scholar
PubMed
Department of Biomedical Sciences, University of Sassari, Viale San Pietro, Sassari, Italy
Search for other papers by Gianfranco Pintus in
Google Scholar
PubMed
SARS-CoV-2 is the agent responsible for the coronavirus disease (COVID-19), which has been declared a pandemic by the World Health Organization. The clinical evolution of COVID-19 ranges from asymptomatic infection to death. Older people and patients with underlying medical conditions, particularly diabetes, cardiovascular and chronic respiratory diseases are more susceptible to develop severe forms of COVID-19. Significant endothelial damage has been reported in COVID-19 and growing evidence supports the key pathophysiological role of this alteration in the onset and the progression of the disease. In particular, the impaired vascular homeostasis secondary to the structural and functional damage of the endothelium and its main component, the endothelial cells, contributes to the systemic proinflammatory state and the multiorgan involvement observed in COVID-19 patients. This review summarizes the current evidence supporting the proposition that the endothelium is a key target of SARS-CoV-2, with a focus on the molecular mechanisms involved in the interaction between SARS-CoV-2 and endothelial cells.
Search for other papers by Laura Monteonofrio in
Google Scholar
PubMed
Search for other papers by Maria Cristina Florio in
Google Scholar
PubMed
Longitudinal Study Section, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA
Division of Cardiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Search for other papers by Majd AlGhatrif in
Google Scholar
PubMed
Search for other papers by Edward G Lakatta in
Google Scholar
PubMed
Division of Cardiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Search for other papers by Maurizio C Capogrossi in
Google Scholar
PubMed
Coronavirus disease 2019 (COVID-19) is a new infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is frequently characterized by a marked inflammatory response with severe pneumonia and respiratory failure associated with multiorgan involvement. Some risk factors predispose patients to develop a more severe infection and to an increased mortality; among them, advanced age and male gender have been identified as major and independent risk factors for COVID-19 poor outcome. The renin-angiotensin-aldosterone system (RAAS) is strictly involved in COVID-19 because angiotensin converting enzyme 2 (ACE2) is the host receptor for SARS-CoV-2 and also converts pro-inflammatory angiotensin (Ang) II into anti-inflammatory Ang(1–7). In this review, we have addressed the effect of aging and gender on RAAS with emphasis on ACE2, pro-inflammatory Ang II/Ang II receptor 1 axis and anti-inflammatory Ang(1–7)/Mas receptor axis.
Search for other papers by Dwitiya Sawant in
Google Scholar
PubMed
Department of Pediatrics, The Ohio State University, Columbus, Ohio, USA
Search for other papers by Brenda Lilly in
Google Scholar
PubMed
miRNAs are small regulatory RNAs which govern gene expression post-transcriptionally by primarily binding to the 3'-UTR of mRNA target genes. miR-145 is a well-studied miRNA that has been implicated in controlling a range of biological processes. miR-145 is expressed in a variety of tissues and cell types and acts as a tumor-suppressor by regulating target gene signaling pathways involved in different aspects of tumor growth and progression. There is also strong evidence that highlights the important functions of miR-145 in the cardiovascular system. Here, we review the mechanisms of miR-145 in tumorigenesis and cancer progression and compare and contrast with the roles of miR-145 in cardiovascular development and disease. We discuss the important targets of miR-145 in cancer and their possible link to the cardiovascular system.
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Search for other papers by Abdallah Al-Mohammad in
Google Scholar
PubMed
Florey Institute for Host Pathogen Research, University of Sheffield, Sheffield, UK
Search for other papers by David G Partridge in
Google Scholar
PubMed
Search for other papers by Graham Fent in
Google Scholar
PubMed
Search for other papers by Oliver Watson in
Google Scholar
PubMed
Search for other papers by Nigel T Lewis in
Google Scholar
PubMed
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Search for other papers by Robert F Storey in
Google Scholar
PubMed
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Search for other papers by Michael Makris in
Google Scholar
PubMed
Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Search for other papers by Timothy J Chico in
Google Scholar
PubMed
Abstract
Since the first description of COVID-19 in December 2019, more than 63,000 publications have described its virology, clinical course, management, treatment and prevention. Most physicians are now encountering, or will soon encounter, patients with COVID-19 and must attempt to simultaneously assimilate this avalanche of information while managing an entirely novel disease with few guiding precedents. It is increasingly clear that, although primarily a respiratory illness, COVID-19 is associated with cardiovascular complications. However, the true incidence of direct cardiac complications remains unclear, as all complications thus far reported can also occur in patients without COVID-19. In this review, we briefly summarise and critically appraise the data on cardiac complications associated with COVID-19 and describe some cases from our own experience. We identify unresolved questions and highlight the many uncertainties in this developing field.
Search for other papers by Kor H Hutting in
Google Scholar
PubMed
Department of Rehabilitation Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Movement Sciences, Amsterdam, the Netherlands
Search for other papers by Wouter B aan de Stegge in
Google Scholar
PubMed
Search for other papers by Rombout R Kruse in
Google Scholar
PubMed
Welsh Wound Innovation Centre, Rhodfa Marics, Ynysmaerdy, Pontyclun, UK
Search for other papers by Jeff G van Baal in
Google Scholar
PubMed
Department of Rehabilitation Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Movement Sciences, Amsterdam, the Netherlands
Search for other papers by Sicco A Bus in
Google Scholar
PubMed
Department of Rehabilitation Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Movement Sciences, Amsterdam, the Netherlands
Search for other papers by Jaap J van Netten in
Google Scholar
PubMed
Monitoring of diabetic foot infections is largely based on clinical assessment, which is limited by moderate reliability. We conducted a prospective study to explore monitoring of thermal asymmetry (difference between mean plantar temperature of the affected and unaffected foot) for the assessment of severity of diabetic foot infections. In patients with moderate or severe diabetic foot infections (International Working Group on the Diabetic Foot infection-grades 3 or 4) we measured thermal asymmetry with an advanced infrared thermography setup during the first 4–5 days of in-hospital treatment, in addition to clinical assessments and tests of serum inflammatory markers (white blood cell counts and C-reactive protein levels). We assessed the change in thermal asymmetry from baseline to final assessment, and investigated its association with infection-grades and serum inflammatory markers. In seven included patients, thermal asymmetry decreased from median 1.8°C (range: −0.6 to 8.4) at baseline to 1.5°C (range: −0.1 to 5.1) at final assessment (P = 0.515). In three patients who improved to infection-grade 2, thermal asymmetry at baseline (median 1.6°C (range: −0.6 to 1.6)) and final assessment (1.5°C (range: 0.4 to 5.1)) remained similar (P = 0.302). In four patients who did not improve to infection-grade 2, thermal asymmetry decreased from median 4.3°C (range: 1.8 to 8.4) to 1.9°C (range: −0.1 to 4.4; P = 0.221). No correlations were found between thermal asymmetry and infection-grades (r = −0.347; P = 0.445), CRP-levels (r = 0.321; P = 0.482) or WBC (r = −0.250; P = 0.589) during the first 4–5 days of hospitalization. Based on these explorative findings we suggest that infrared thermography is of no value for monitoring diabetic foot infections during in-hospital treatment.
